Penserra Capital Management LLC Rvl Pharmaceuticals PLC Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$0.98 - $3.06 $1,411 - $4,406	-1,440 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.79 - $4.19 $27 - $41	10 Added 0.7%	1,440 $4,000
Q2 2021 Aug 12, 2021	BUY	$2.8 - $3.78 $28 - $37	10 Added 0.7%	1,430 $4,000
Q1 2021 May 13, 2021	SELL	$3.26 - $4.84 $179 - $266	-55 Reduced 3.73%	1,420 $4,000
Q4 2020 Feb 12, 2021	BUY	$4.12 - $6.29 $3,835 - $5,855	931 Added 171.14%	1,475 $6,000
Q3 2020 Nov 13, 2020	BUY	$4.82 - $8.77 $2,622 - $4,770	544 New	544 $2,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.